68 related articles for article (PubMed ID: 17188604)
1. Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance.
Regan FM; Williams RM; McDonald A; Umpleby AM; Acerini CL; O'Rahilly S; Hovorka R; Semple RK; Dunger DB
J Clin Endocrinol Metab; 2010 May; 95(5):2113-22. PubMed ID: 20233784
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency.
Muthuvel G; Al Remeithi SS; Foley C; Dauber A; Hwa V; Backeljauw P
Horm Res Paediatr; 2024; 97(2):195-202. PubMed ID: 37586336
[TBL] [Abstract][Full Text] [Related]
3. IGF-I treatment of insulin resistance.
McDonald A; Williams RM; Regan FM; Semple RK; Dunger DB
Eur J Endocrinol; 2007 Aug; 157 Suppl 1():S51-6. PubMed ID: 17785698
[TBL] [Abstract][Full Text] [Related]
4. A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness.
Dauber A; Meng Y; Audi L; Vedantam S; Weaver B; Carrascosa A; Albertsson-Wikland K; Ranke MB; Jorge AAL; Cara J; Wajnrajch MP; Lindberg A; Camacho-Hübner C; Hirschhorn JN
J Clin Endocrinol Metab; 2020 Oct; 105(10):3203-14. PubMed ID: 32652002
[TBL] [Abstract][Full Text] [Related]
5. Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.
Chen YS; Hong ZX; Lin SZ; Harn HJ
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357546
[TBL] [Abstract][Full Text] [Related]
6. Diabetes in a child on growth hormone therapy: Answers.
Aldridge M; Huynh T; Prado J; McTaggart SJ
Pediatr Nephrol; 2018 Jan; 33(1):79-80. PubMed ID: 28349214
[No Abstract] [Full Text] [Related]
7. Growth retardation in children with kidney disease.
Salas P; Pinto V; Rodriguez J; Zambrano MJ; Mericq V
Int J Endocrinol; 2013; 2013():970946. PubMed ID: 24187550
[TBL] [Abstract][Full Text] [Related]
8. Human conditions of insulin-like growth factor-I (IGF-I) deficiency.
Puche JE; Castilla-Cortázar I
J Transl Med; 2012 Nov; 10():224. PubMed ID: 23148873
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?
Balhara B; Misra M; Levitsky LL
Indian J Pediatr; 2012 Feb; 79(2):244-9. PubMed ID: 22090255
[TBL] [Abstract][Full Text] [Related]
10. Glucose lowering effect of transgenic human insulin-like growth factor-I from rice: in vitro and in vivo studies.
Cheung SC; Liu LZ; Lan LL; Liu QQ; Sun SS; Chan JC; Tong PC
BMC Biotechnol; 2011 Apr; 11():37. PubMed ID: 21486461
[TBL] [Abstract][Full Text] [Related]
11. Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.
Fintini D; Brufani C; Cappa M
Ther Clin Risk Manag; 2009 Jun; 5(3):553-9. PubMed ID: 19707272
[TBL] [Abstract][Full Text] [Related]
12. Progression of glomerular and tubular disease in pediatrics.
Woroniecki RP; Schnaper HW
Semin Nephrol; 2009 Jul; 29(4):412-24. PubMed ID: 19615562
[TBL] [Abstract][Full Text] [Related]
13. Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.
Murthy SN; Sukhanov S; McGee J; Greco JA; Chandra S; Delafontaine P; Kadowitz PJ; McNamara DB; Fonseca VA
Mol Cell Biochem; 2009 Oct; 330(1-2):1-8. PubMed ID: 19360379
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone axis in chronic kidney disease.
Mahesh S; Kaskel F
Pediatr Nephrol; 2008 Jan; 23(1):41-8. PubMed ID: 17676425
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
Rosenbloom AL
J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
[No Abstract] [Full Text] [Related]
16. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
Richmond EJ; Rogol AD
Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
Clark RG
Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
[TBL] [Abstract][Full Text] [Related]
18. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
Wang W; Iresjö BM; Karlsson L; Svanberg E
Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic applications of the insulin-like growth factors.
Savage MO; Camacho-Hübner C; Dunger DB
Growth Horm IGF Res; 2004 Aug; 14(4):301-8. PubMed ID: 15231299
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
